COSMOS HEALTH INC COSM
ASignal's systematic analysis rates COSM as Bearish.
Reflects the latest available analysis · analyzed Nov 13, 2026
The case on COSM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (28.8% YoY)
- Low price-to-sales ratio (0.24x) indicating potential undervaluation
- Low enterprise value to revenue (0.47x)
- Growth score of 0.9 suggests high growth potential
- Negative profit and operating margins
- Negative return on equity (-104%) and return on assets (-18.42%)
- Negative free cash flow (-$10.07M)
- High debt-to-equity ratio (0.77x)
- Low current and quick ratios indicating liquidity concerns
- EV/EBITDA negative at -2.09x suggesting valuation challenges
See the full verdict on COSM
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes COSM
Most investors never get a second opinion, let alone several. ASignal runs COSM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.